SVRA – savara, inc. (US:NASDAQ)
Stock Stats
News
Savara Announces New Employment Inducement Grant
Savara Announces the U.S. Food & Drug Administration (FDA) Has Extended the Review Period for the Molgramostim Inhalation Solution (Molgramostim) Biologics License Application (BLA) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
Savara To Present New Data at the American Thoracic Society (ATS) 2026 International Conference
Savara Announces the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) Has Accepted the MOLBREEVI* Marketing Authorisation Application (MAA) for Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
Savara Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) for MOLBREEVI* in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) [Yahoo! Finance]
Form PRE 14A Savara Inc For: Jun 04
Form 4 Savara Inc For: Mar 18 Filed by: Lowrance David L
Form 8-K Savara Inc For: Mar 10
Form 10-K Savara Inc For: Dec 31
Form SCHEDULE 13G/A Savara Inc Filed by: Venrock Healthcare Capital Partners III, L.P.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.